Looking for information about IMMUNE PHARMACEUTICALS HEADQUARTERS? Follow the links below to find all the information you are interested in. Addresses, telephones, emails, working hours and other useful information.


Immune Pharmaceuticals - Crunchbase Company Profile & Funding

    https://www.crunchbase.com/organization/immune-pharmaceuticals
    Nov 08, 2012 · Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date 2010. Founders Daniel Teper, Jean Kadouche. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Immune Pharmaceuticals, Inc. Stock Symbol OTCQB:IMNP. Company Type For Profit. Phone Number 914-606-3500.Founded: 2010

Immune Pharmaceuticals Inc - Company Profile and News ...

    https://www.bloomberg.com/profile/company/IMNP:US
    Immune Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company provides novel therapeutic agents for the treatment of immunologic and inflammatory diseases.Employees: 7

IMMUNE PHARMACEUTICALS INC (IMNPQ) Company Profile & …

    https://finance.yahoo.com/quote/IMNPQ/profile/
    Immune Pharmaceuticals, Inc. was founded in 2010 and is based in Fort Lee, New Jersey. On April 2, 2020, the voluntary petition of Immune Pharmaceuticals, Inc. along with its affiliates, for ...

Immune Pharmaceuticals Inc. LinkedIn

    https://www.linkedin.com/company/immune-pharmaceuticals-ltd-
    Immune Pharmaceuticals Inc. (OTCQB: IMNP) is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune’s lead program ...

IMMUNE PHARMACEUTICALS INC (IMNPQ) Stock Price, News ...

    https://finance.yahoo.com/quote/IMNPQ/
    Find the latest IMMUNE PHARMACEUTICALS INC (IMNPQ) stock quote, history, news and other vital information to help you with your stock trading and investing.Ask: 0.0000 x 0

Immune Pharmaceuticals Completes Merger with EpiCept ...

    https://www.prnewswire.com/news-releases/immune-pharmaceuticals-completes-merger-with-epicept-corporation-221116351.html
    Aug 26, 2013 · Immune Pharmaceuticals Inc. (OTCQX: EPCTD, Nasdaq OMX Stockholm Exchange: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the ...Estimated Reading Time: 9 mins

Anti-Müllerian Hormone Signaling Regulates Epithelial ...

    https://pubmed.ncbi.nlm.nih.gov/27396341/
    Anti-Müllerian hormone (AMH) and its type II receptor AMHR2, both previously thought to primarily function in gonadal tissue, were unexpectedly identified as potent regulators of transforming growth factor (TGF-β)/bone morphogenetic protein (BMP) signaling and …

Julia V - SDSC

    https://www.sdsc.edu/~jpon/
    Julia V. Ponomarenko, Ph.D. Senior Research Scientist, Computational Biology. San Diego Supercomputer Center, Skaggs School of Pharmacy & Pharmaceutical Science. University of California, San Diego. 9500 Gilman Drive, MC 0743, La Jolla, CA 92093. (858) 822-5415,

Novel Software Systems - BioIT R&D company LinkedIn

    https://www.linkedin.com/company/novel-soft
    Novel Software Systems is specialized in scientific software development and biological BigData analysis. Currently our team consists of more than 40 high qualified software developers ...

Immune Pharmaceuticals: 5 Big Warning Signs (OTCMKTS:IMNPQ ...

    https://seekingalpha.com/article/3917236-immune-pharmaceuticals-5-big-warning-signs
    Feb 22, 2016 · Immune Pharmaceuticals (NASDAQ:IMNP) has a terrific story.Its drug bertilimumab inhibits eotaxin-1, a protein that regulates allergic responses, and …

In addition to information on IMMUNE PHARMACEUTICALS HEADQUARTERS, our site contains many other interesting information about corporate offices. We invite you to view the pages with related information.

Related Corporate Office Information: